Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.

Virology - 1 Jan 2015

Felt Sébastien A, Moerdyk-Schauwecker Megan J, Grdzelishvili Valery Z

Abstract excerpt

Effective oncolytic virus (OV) therapy is dependent on the ability of replication-competent viruses to kill infected cancer cells. We previously showed that human pancreatic ductal adenocarcinoma (PDAC) cell lines are highly heterogeneous in their permissiveness to vesicular stomatitis virus (VSV), in part due to differences in type I interferon (IFN) signaling. Here, using 10 human PDAC cell lines and three...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carcinoma, Pancreatic Ductal
Share to Interferon Type I
Share to Oncolytic Virotherapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Oncolytic Viruses

Share to Pancreatic Neoplasms

Share to Vesicular stomatitis Indiana virus

Share to Viral Matrix Proteins

Share to Virus Replication

Source

Open in PubMed Open full text

Identifiers

PMID: 25463614
DOI: 10.1016/j.virol.2014.10.026
PMCID: PMC4259820

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Induction of apoptosis in pancreatic cancer cells by vesicular stomatitis virus.PMID 25463614Read ↗

Vesicular Stomatitis Virus as an Oncolytic Agent against Pancreatic Ductal AdenocarcinomaSemantic proximity Read ↗

Expanding the Spectrum of Pancreatic Cancers Responsive to Vesicular Stomatitis Virus-Based Oncolytic Virotherapy: Challenges and SolutionsSemantic proximity Read ↗

Novel biomarkers of resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virus.Semantic proximity Read ↗

Oncolytic Activity of Vesicular Stomatitis Virus Is Effective against Tumors Exhibiting Aberrant p53, Ras, or Myc Function and Involves the Induction of ApoptosisSemantic proximity Read ↗

Intertumoral heterogeneity impacts oncolytic vesicular stomatitis virus efficacy in mouse pancreatic cancer cellsSemantic proximity Read ↗

Vesicular stomatitis viruses expressing wild-type or mutant M proteins activate apoptosis through distinct pathways.Semantic proximity Read ↗

Experimental Evolution Generates Novel Oncolytic Vesicular Stomatitis Viruses with Improved Replication in Virus-Resistant Pancreatic Cancer Cells.Semantic proximity Read ↗

Acquired chemoresistance can lead to increased resistance of pancreatic cancer cells to oncolytic vesicular stomatitis virusSemantic proximity Read ↗

MAVS-Mediated Apoptosis and Its Inhibition by Viral ProteinsSemantic proximity Read ↗

The modulation of apoptosis by oncogenic virusesSemantic proximity Read ↗

Oncolytic virotherapy for pancreatic cancer.Semantic proximity Read ↗

Avian influenza virus as an oncolytic therapy for pancreatic cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.